Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Scandal-ridden PIP implant firm had been on FDA's radar since 2000

This article was originally published in Clinica

Executive Summary

The company at the heart of the recent French silicone breast implant furore, Poly Implant Prosthèse (PIP), had given the US FDA cause for concern as far back as 2000 when an agency inspection of the firm's facility in La Seyne-sur-mer revealed manufacturing and quality control issues.


Related Content

EU MDR Set To Rack Up Costs For Industry, German Medtechs Say





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts